James W. Dear
Impact in
- Pharmacology top 0.1%
- Drug-Induced Hepatotoxicity and Protection
- Nephrology top 0.5%
- Acute Kidney Injury Research
Papers in
- Pharmacology 63
- Drug-Induced Hepatotoxicity and Protection 60
-
- Poisoning and overdose treatments 35
- Co-authors
- David J. WebbRobert A. StarA. D. Bastiaan VliegenthartJonathan M. StreetD. Nicholas BatemanDaniel J. AntoineMatthew A. BaileyStephen M. Hewitt
- Journals
- British Journal of Clinical Pharmacology (18 papers)Clinical Toxicology (13 papers)Kidney International (7 papers)British Journal of Pharmacology (5 papers)Hypertension (5 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
James W. Dear
153 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Pharmacology 1.4k
- Nephrology 801
- Cancer Research 1.4k
- Hepatology 622
- Emergency Medicine 540
Countries citing papers authored by James W. Dear
This map shows the geographic impact of James W. Dear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Dear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Dear more than expected).
Fields of papers citing papers by James W. Dear
This network shows the impact of papers produced by James W. Dear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Dear. The network helps show where James W. Dear may publish in the future.
Co-authors
The 25 scholars most cited alongside James W. Dear, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 16 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 30 | |
| 9 | 2022 | 81 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 13 | |
| 12 | 2021 | 12 | |
| 13 | 2019 | 31 | |
| 14 | 2019 | 1 | |
| 15 | 2019 | 18 | |
| 16 | 2016 | 49 | |
| 17 | Leptin Induces Hypertension and Endothelial Dysfunction via Aldosterone-Dependent Mechanisms in Obese Female Mice | 2016 | 28 |
| 18 | 2014 | 25 | |
| 19 | Cyclophilin A is a Key mediator of Paracetamol Poisoning | 2010 | 1 |
| 20 | Scottish Medicines Consortium | 2007 | 3 |
About James W. Dear
James W. Dear is a scholar working on Pharmacology, Emergency Medicine, Nephrology, Hepatology and Cancer Research, having authored 158 papers that have together received 6.3k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (60 papers), Poisoning and overdose treatments (35 papers), MicroRNA in disease regulation (22 papers), Extracellular vesicles in disease (14 papers), Liver Disease and Transplantation (13 papers), Liver Disease Diagnosis and Treatment (13 papers), Acute Kidney Injury Research (11 papers) and Advanced biosensing and bioanalysis techniques (10 papers). The work is most often cited by research in Pharmacology (1.4k citations), Nephrology (801 citations), Cancer Research (1.4k citations), Hepatology (622 citations) and Emergency Medicine (540 citations). James W. Dear has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include David J. Webb, Robert A. Star, A. D. Bastiaan Vliegenthart, David J. Webb, Jonathan M. Street, D. Nicholas Bateman, Daniel J. Antoine, Matthew A. Bailey, Stephen M. Hewitt and Peter S.T. Yuen. Their work appears in journals such as British Journal of Clinical Pharmacology, Clinical Toxicology, Kidney International, British Journal of Pharmacology and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.